PRODUCT INFORMATION - Medsafe
version: czm pi anz a1204-01 supercedes: czm anz a1003-01 commercial page 1 of 11 product information cerezyme® name of the medicine non-proprietary name
Information, Product, Product information, Cerezyme, Product information cerezyme
Download PRODUCT INFORMATION - Medsafe
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Procedures, programs and drugs you must precertify
www.aetna.comProcedures, programs and drugs you must precertify Participating provider precertification list Effective July 1, 2018 . Applies to. 1,2,3,4,9: Aetna
Ingredient 200 Unit Vial - Cerezyme
www.cerezyme.comDESCRIPTION Cerezyme® (imiglucerase for injection) is an analogue of the human enzyme ß-glucocerebrosidase, produced by recombinant DNA technology. ß-Glucocerebrosidase (ß-D-glucosyl-N-acylsphingosine
List of Designated High-Cost Drugs for Reduced …
www.gov.mb.caList of Designated High-Cost Drugs for Reduced Wholesale Upcharge Updated July 1, 2018 Page 1 of 7 DIN Chemical Description Product Name Allowable
Drug, Cost, Wholesale, Reduced, Cost drugs for reduced, Cost drugs for reduced wholesale upcharge, Upcharge
REQUEST FOR PRIOR AUTHORIZATION FAX (559) …
www.santehealth.netREQUEST FOR PRIOR AUTHORIZATION FAX (559) 224-2405 or (559) 224-9746 PHONE (559) 228-5400 or (800) 652-2900 O Aqua Therapy O …
Volume 42, Number 4, pp 378–382 2007 Wolters …
www.seanmeskill.com378 Volume 42, April 2007 Special Resource Hospital Pharmacy Volume 42, Number 4, pp 378–382 2007 Wolters Kluwer Health, Inc. Drugs to …
Health, Volume, 2007, Number, Trowel, Volume 42, Number 4, Pp 378 382 2007 wolters, Pp 378 382 2007 wolters kluwer health, Kluwer
Do Not Tube List for Pharmaceuticals (Revised July …
mc.vanderbilt.eduDo Not Tube List for Pharmaceuticals (Revised July 2015) 1=Drug Alteration 2=Expense 3=Flammable 4= Product Foaming 5=Short Exp/Admin Time
Prior Authorization Requirements - Health Net
www.healthnet.comCalifornia Medi-Cal FFS providers in Los Angeles, Sacramento, San Diego, San Joaquin, Stanislaus, and Tulare counties; and Fresno, Kings and Madera counties